BLOG: New DVD / BluRay Releases HHSE Investor

New Post Public Reply Private Reply Replies (0) Message Board
speckulater
243
BLOG: New DVD / BluRay Releases



HHSE Investor Relations



Wednesday, September 30, 2020

Major Retailer plans for Q1 (2021) Enable HHSE to finally schedule new DVD / BluRay Releases

Greetings HHSE Friends & Followers - After nearly two (2) years of NO NEW RELEASE ACTIVITY for home video products, HHSE is finally able to formalize release dates for a series of titles that have been held back due to market conditions (and COVID impact on retailers). Watch for these new releases (and new edition re-releases) coming in Q1 (2021) and shortly thereafter from HHSE / Medallion:



MARCH 2, 2021

HEXING - Sci-Fi Horror starring Dominique Swain (DVD / BluRay)

Gross Sales Forecast: $65,000

RIDE UNITED - Redbull Motorsports (DVD / BluRay)

Gross Sales Forecast: $30,000



MARCH 30, 2021

MANHUNTERS - Action Adventure (DVD / BluRay)

Gross Sales Forecast: $115,000

AMERICA UNITED - Concert Special (DVD / BluRay)

Gross Sales Forecast: $20,000

SPICES OF LIBERTY - Comedy with South-India audience appeal (DVD / BluRay)

Gross Sales Forecast: $35,000



APRIL 20, 2021

SACRED PREY - Trade edition / Fiction Book

Gross Sales Forecast: $30,000

EASY LOVE - Foreign Art Film (Streaming, DVD / BluRay)

Gross Sales Forecast: $55,000



TOTAL GROSS SALES FORECAST (all seven items): $345,000

(Approx. HHSE "margin": $85,000, plus $25,000 in recoupment)



Except for MANHUNTERS, these were all previously acquired titles or re-release promotions that were DELAYED due to the evolving retail marketplace and changes that occurred as a result of the retail shopping impact caused by COVID-19. With most of the preparation costs completed for these releases, the benefit to HHSE is quite good as there are not significant expenses at this point other than direct cost of goods and freight. So it will be a nice little bonus revenue stream in Q1 to add to the company's substantial production services fees (for the new feature productions) as well as the MyFlix (HHSE) share of 50% of the net on all MyFlix producer revenues. Primary retail commitments fueling these specific title sales forecasts are from: Best Buy, Family Video, Redbox and Barnes & Noble. The company will not be pursuing Walmart placements on these secondary releases, due to Walmart's requirement of approx. 25,000 units of inventory per DVD placement (which is an inventory level greater than the realistic retail unit depletions for these items).

With HHSE now having a monthly overhead of less than $10,000 (excluding MYFLIX and PRODUCTIONS which overhead costs are funded separately and off-balance-sheet), reinstating a release slate of smaller titles actually becomes a nice bottom-line profit for the company.

GO HHSE!




HEXING, Trailer:

https://www.youtube.com/watch?v=nGiAJJVSCeE



MANHUNTERS (aka "Redneg" Trailer:

https://www.youtube.com/watch?v=pmMT_y2zx5o



EASY LOVE, Trailer:

https://www.youtube.com/watch?v=wNxYVjNaDHM



Five (5) Pictures of Movies


http://hannoverhousemovies.blogspot.com/2020/...nable.html



HHSE

Hannover House Inc. (HHSE) Stock Research Links

HHSE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Peptide Therapy Rules Change: Gameday Ups the Ante

Updated Category News Views 110

Gameday Men's Health: Leading the Safe Peptide Charge Finally, we got some regulatory sanity stepping up to the plate with peptides. You see, the FDA's new interim policy is letting state-licensed compounding pharmacies work their magic with peptides, but only under strict medical watch. And Gameday Men's Health sure ain't wasting any time setting up shop in this fresh...

Continue Reading
Markel's Reinsurance Shift with $4.8B Deal: Strategic Move?

Updated Category News Views 100

Weaving Through Complex Insurance Terrain When Markel Insurance pulls a move on the chessboard that involves $4.8 billion in subject reserves, we better pay attention. The insurance bigwig has inked a reinsurance deal with Enstar. This plan, they say, will help them focus more on their specialty insurance game while tidying up the loose ends in their global reinsurance...

Continue Reading
Hollywood Vampires' Limited Art Sparks Las Vegas Buzz

Updated Category News Views 117

A Collaboration to Captivate Art and Rock Enthusiasts When it comes to mixing rock and roll with fine art, Markus Klinko's exclusive photograph featuring the Hollywood Vampires hits the nail on the head. It’s not just an image; it’s a slice of modern rock history immortalized on paper. This new release, a portrait capturing the raw passion of Alice Cooper, Johnny...

Continue Reading
?atwogang Leads Tiltify's Impact Creator Class of 2026

Updated Category News Views 60

Charity Meets Creativity: A New Era Unveiled Who would have thought? Charitable fundraising is no longer just about writing checks. It's about creativity, community, and leveraging tech to drive change. Enter Tiltify's Creator Impact Class of 2026—proof that we're living in a brave new world where internet creators are the kings and queens of giving. ?atwogang Takes...

Continue Reading
Alchemy's Texas Move: Strategic Growth or Gamble?

Updated Category News Views 80

Making a Splash in Texas IT Services Alchemy Technology Group's acquisition of Freeit Data Solutions isn't just another drop in the tech pond; it's a cannonball aimed at shaking up the IT and cybersecurity scenes in Texas. By bringing Freeit's impressive 16-year track record under its wing, Alchemy is flexing its muscles in a region already bustling with IT infrastructure...

Continue Reading
Group 1 Automotive Q3 2026: Profits Soar, Revenues Dip

Updated Category News Views 34

Profits Up, Revenues Down Here's a tale for the books—Group 1 Automotive reports their third quarter results of 2026 and it's a bit like swapping a thunderstorm for a hurricane. Net income from continuing operations stomped on last year's figures, clocking in at a hefty $102.9 million compared to a skimpy $13.1 million. But don't let that fool you, their total revenues...

Continue Reading
Lilly's Retatrutide Outshines Ozempic in Key Diabetes Trial

Updated Category News Views 49

Lilly's Breakthrough in Diabetes Treatment Eli Lilly's retatrutide is stirring up the diabetes treatment waters. The latest Phase 3 comparison to Ozempic's top dose reveals some surprising results. I'm not one to toss out kudos lightly, but this could be a genuine game-changer if things hold steady. A1C Reductions: A Close Look at the Numbers We’re staring down the...

Continue Reading
Miracle League Marks Two Decades with Big Fundraising Win

Updated Category News Views 66

A Double Decade Celebration of Dream and Dedication The Miracle League of the Triangle sure knows how to throw a party—for them, it's not just a gala; it's a testament to two decades of turning dreams into reality. On October 13th, over 300 guests gathered at the Angus Barn Pavilion in Cary, NC, proving that passion for inclusive baseball is just as alive as it was 20...

Continue Reading
Palmdale Propane Expands with Affordable Gas Buy

Updated Category News Views 50

Propane Power Play in Florida's Market Here's a little tune you don't hear every day: two local businesses tangoing to the beat of expansion without making a public peep about the price. Palmdale Propane, a powerhouse under the Palmdale Oil umbrella, just snapped up Affordable Gas, a local player from Belle Glade, Florida. This acquisition strengthens its grip on the...

Continue Reading
Northeast Indiana Bancorp Shows Solid Third Quarter Gains

Updated Category News Views 47

Holding Steady in a Shaky Market In a market often rocked by turbulence, it seems Northeast Indiana Bancorp, Inc. has found a decent footing to stand on. Announcing their third-quarter results for 2026, they’ve posted net income of $1.991 million, showcasing a neat jump from the $1.793 million in the same period last year. Not bad at all for the parent company of First...

Continue Reading

Top 5 Most Recently Viewed Articles

Boosty Labs Elevates Leadership to Fuel 2025 Vision

Updated Category News Views 170

Boosty Labs Moves Forward with Strategic Leadership Changes Boosty Labs, a prominent name in Blockchain, Bitcoin, and Web3 development, is taking a substantial leap forward. As the company prepares for significant growth, the leadership team has undergone key changes aimed at driving operational excellence and innovation. New Roles for Vitalii Yatskiv and Denys Doronin In...

Continue Reading
Sinclair Inc. Elevates Leadership With Key Promotions

Updated Category News Views 236

Sinclair Inc. Elevates Leadership With Key Promotions BALTIMORE - Sinclair Inc. (NASDAQ: SBGI), a significant force in the media landscape recognized for its local news and sports coverage, with a market capitalization of $963 million, has recently elevated several key executives within its organizational structure and various subsidiaries. These strategic executive...

Continue Reading
Nasus Pharma's IPO: Paving the Way for Innovative Treatments

Updated Category News Views 172

Nasus Pharma Completes Initial Public Offering Nasus Pharma Ltd. (NYSE: NSRX) recently celebrated the successful conclusion of its initial public offering (IPO), marking a significant milestone for the company. This clinical-stage pharmaceutical firm, based in Israel, specializes in developing innovative intranasal products designed for treating emergency medical...

Continue Reading
Discover the Compact Keurig® K-Mini Mate™ Brewer Today

Updated Category News Views 105

Introducing the Keurig® K-Mini Mate™ Brewer The world of coffee brewing has evolved with the introduction of the Keurig® K-Mini Mate™ Brewer. This remarkable machine, available exclusively at Target, marks a significant leap in convenience and taste. Notably small at just 4 inches wide, this brewer is perfect for anyone who values space without wanting to sacrifice...

Continue Reading
Explore Telix Pharmaceuticals' Latest Innovations in Urology

Updated Category News Views 179

Join Telix Pharmaceuticals for a Pioneering Webinar Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX) is excited to extend an invitation to investors for a comprehensive webinar centered on the company’s leading-edge developments in urology. This event will highlight innovative approaches to treating prostate and kidney cancers, showcasing the remarkable potential...

Continue Reading